Анализ эпидемической вспышки коклюша в Республике Молдова
https://doi.org/10.31631/2073-3046-2017-16-3-96-100
Аннотация
Ключевые слова
Об авторах
В. . БуковаРоссия
А. . Мельник
Россия
Л. . Цуркан
Россия
А. . Чебан
Россия
В. . Гуцу
Россия
Список литературы
1. Pertussis vaccines: WHO position paper. Weekly epidemiological record. 2015; 35 (90): 433 - 460. Доступно на: http://www.who.int/wer.
2. Porteous G.H., Hanson N.A., Sueda L.A., Hoaglan C.D.,Dahl A.B, Ohlson B.B. et al. Resurgence of vaccine-preventable diseases in the United States: anesthetic and critical care implications. Anesth Analg. 2016 May; 122 (5): 1450-73. doi: 10.1213/ANE. 0000000000001196.
3. Shuel M., Lefebvre B., Whyte K., Hayden K., De Serres G., Brousseau N. et al. Antigenic and genetic characterization of Bordetella pertussis recovered from Quebec, Canada, 2002 -2014. Can. J.Microbiol. 2016 May; 62 (5):437 -41. doi: 10.1139/cjm-2015-0781. Epub 2016 Jan 14.detection of a genetic shift.
4. Н. И. Брико, Миндлина А.Я., Полибин Р.В. Универсальность изменений в проявлениях эпидемического процесса антропонозных инфекций за последние десятилетия. Журнал микробиологии. 2015; (5): 12 - 20.
5. de Cell s M.D., Felicia M.G. Magpantay, A.A. King, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc., Biol., Sci. 2016 Jan 13; 283 (1822):20152309. doi: 10.1098/rspb.2015.2309 PMCID: PMC4721090.
6. Palazzo R., Carollo M., Bianco M., Fedele G., Schiavoni I., Pandolfi E. et al. Persistence of T-cell immune response induced by two acellular pertussis vaccines in children five years after primary vaccination. New Microbiol. 2016 Jan; 39 (1): 35 - 47.
7. Wanlapakorn N., Ngaovithunvong V., Thongmee T., Vichaiwattana P., Vongpunsawad S. et al. Seroprevalence of antibodies to pertussis toxin among different age groups in Thailand after 37 years of universal whole-cell pertussis vaccination. PLoS One. 2016 Feb 2; 11 (2): e0148338. doi: 10.1371/journal. pone.0148338. eCollection 2016.
8. Zahn M. Just when you think you know someone: the evolving epidemiologies of measles and pertussis. Curr Opin Pediatr. 2016 Feb 28; (1): 101 - 6. doi: 10.1097/MOP.0000000000000307.
9. Clarkson J.A. The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Fine PE. 1982. Lancet (1): 666 - 669. doi:10.1016/S0140-6736(82)92214-0 [PubMed].
10. Warfel J.M., Zimmerman L.I., Merkel T.J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Natl., Acad., Sci., USA. Proc. 2014; (111): 787 - 792. doi:10.1073/pnas.1314688110 [PMC free article] [PubMed].
11. Wendelboe A.M., Van Rie A., Salmaso S., Englund J.A. Duration of immunity against pertussis after natural infection or vaccination. Pediatr. Infect. Dis. 2005; (24): 58 - S61. doi:10.1097/01.inf.0000160914.59160.41. [PubMed].
12. Phadke V.K., Bednarczyk R.A., Salmon D.A., Omer S.B. Association between vaccine refusal and vaccine-preventable diseases in the United States. A Review of Measles andPertussis. JAMA. 2016 Mar 15; 315 (11): 1149 - 58. doi: 10.1001/jama.2016.1353.
13. Van den Biggelaar A.H., Poolman J.T. Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization. Expert Rev. Vaccines. 2016; 15 (1): 69 - 80. doi: 10.1586/14760584.2016.1105136. Epub. 2015; 11.
14. Campbell P.T., McCaw J.M., McIntyre P. Defining long-term drivers of pertussis resurgence and optimal vaccine control strategies McVernon J. Vaccine 2015 Oct 26; 33 (43): 5794 - 800. doi:10.1016/j.vaccine. 2015.09.025. Epub 2015 Sep 19.
15. Koh M.T., Liu C.S., Chiu C.H., Boonsawat W., Watanaveeradej V., Abdullah N. et al., Under-recognized pertussis in adults from Asian countries: a crosssectional seroprevalence study in Malaysia, Taiwan and Thailand. Epidemiol. Infect. 2016 Apr 14; 4 (6): 1192 - 1200. doi: 10.1017/S0950268815002393. Epub 2015 Oct 15.
16. Cherry J.D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin., Infect., 1999; Dis.28 (Suppl, 2): 112 - 117. doi:10.1086/515058. [PubMed].
17. von Knig C.H.W., Halperin S., Riffelmann M., Guiso N. Pertussis of adults and infants. Lancet Infect., Dis. 2002; (2): 744 - 750. doi:10.1016/S1473-3099(02)00452-8. [PubMed].
18. Mooi F.R. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect. Genet. 2010; Evol. (10): 36 - 49. doi:10.1016/j.meegid.2009.10.007. [PubMed].
19. Bart M.J. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. 2014; mBio 5, e01074. doi:10.1128/ mBio.01074-14. [PMC free article]. [PubMed].
Рецензия
Для цитирования:
Букова В., Мельник А., Цуркан Л., Чебан А., Гуцу В. Анализ эпидемической вспышки коклюша в Республике Молдова. Эпидемиология и Вакцинопрофилактика. 2017;16(3):96-100. https://doi.org/10.31631/2073-3046-2017-16-3-96-100
For citation:
Bukova V., Melnik A., Tsurcan L., Cheban A., Gutsu V. Pertussis Outbreak Analysis in Republic of Moldova. Epidemiology and Vaccinal Prevention. 2017;16(3):96-100. (In Russ.) https://doi.org/10.31631/2073-3046-2017-16-3-96-100